Page last updated: 2024-08-24

1-beta-d-arabinofuranosylcytosine 5'-monophosphate and Hepatocellular Carcinoma

1-beta-d-arabinofuranosylcytosine 5'-monophosphate has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyer, SH; Craigo, W; Erion, MD; Esterbrook, J; Gómez-Galeno, JE; Jiang, H; MacKenna, DA; Reddy, KR; Sun, Z; Ugarkar, BG1

Other Studies

1 other study(ies) available for 1-beta-d-arabinofuranosylcytosine 5'-monophosphate and Hepatocellular Carcinoma

ArticleYear
Synthesis and characterization of a novel liver-targeted prodrug of cytosine-1-beta-D-arabinofuranoside monophosphate for the treatment of hepatocellular carcinoma.
    Journal of medicinal chemistry, 2006, Dec-28, Volume: 49, Issue:26

    Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Bone Marrow; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Cytidine Monophosphate; Hepatocytes; Liver; Liver Neoplasms; Male; Mice; Prodrugs; Rats; Tissue Distribution

2006